These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6424378)

  • 1. Hereditary dysfibrinogenemia--the first 25 years.
    Bithell TC
    Acta Haematol; 1984; 71(3):145-9. PubMed ID: 6424378
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinogen kaiserslautern III: a new case of congenital dysfibrinogenemia with aalpha 16 arg-->cys substitution.
    Loreth RM; Meyer M; Albert FW
    Haemostasis; 2001; 31(1):12-7. PubMed ID: 11408744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepant elimination of fibrin des-AA and des-AABB in man.
    Nilsen DW; Brosstad F
    Thromb Haemost; 1986 Jun; 55(3):439. PubMed ID: 3750275
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrin polymerization sites in fibrinogen and fibrin fragments.
    Budzynski AZ; Olexa SA; Pandya BV
    Ann N Y Acad Sci; 1983 Jun; 408():301-14. PubMed ID: 6575691
    [No Abstract]   [Full Text] [Related]  

  • 5. Hereditary dysfibrinogenemia characterized by slow fibrinopeptide release and competitive inhibition of thrombin.
    Laugen RH; Bithell TC
    Acta Haematol; 1984; 71(3):150-7. PubMed ID: 6424379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of thrombin and fibrinogen and the polymerization of fibrin monomer.
    Scheraga HA
    Ann N Y Acad Sci; 1983 Jun; 408():330-43. PubMed ID: 6575693
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrinogen Petoskey: identification of a new dysfibrinogenemia characterized by altered release of fibrinopeptide A.
    Higgins DL; Penner JA; Shafer JA
    Thromb Res; 1981 Sep; 23(6):491-504. PubMed ID: 6459662
    [No Abstract]   [Full Text] [Related]  

  • 8. Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis.
    Al-Mondhiry H; Galanakis D
    J Lab Clin Med; 1987 Dec; 110(6):726-33. PubMed ID: 3119749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen Nijmegen: congenital dysfibrinogenemia associated with impaired t-PA mediated plasminogen activation and decreased binding of t-PA.
    Engesser L; Koopman J; de Munk G; Haverkate F; Nováková I; Verheijen JH; Briët E; Brommer EJ
    Thromb Haemost; 1988 Aug; 60(1):113-20. PubMed ID: 3142089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular markers of hemostatic mechanisms--fibrinopeptide A and fibrinopeptide B beta 15-42].
    Kobayashi N
    Rinsho Byori; 1989 Mar; 37(3):231-3. PubMed ID: 2746916
    [No Abstract]   [Full Text] [Related]  

  • 11. Crosslinking of monomeric fibrin by factor XIIIa.
    Dardik BN; Shainoff JR
    Thromb Haemost; 1979 Oct; 42(3):864-72. PubMed ID: 505402
    [No Abstract]   [Full Text] [Related]  

  • 12. Domains in fibrinogen of importance for the fibrinogen-fibrin formation.
    Hessel B; Kudryk B; Bombäck B
    Bibl Haematol; 1977; 44():117-22. PubMed ID: 617775
    [No Abstract]   [Full Text] [Related]  

  • 13. Proceedings: Differences in crosslinking reactivity of fibrin molecules formed during differential release of fibrinopeptides A and B.
    Furlan M; Seelich T; Beck EA
    Thromb Diath Haemorrh; 1975 Nov; 34(2):550. PubMed ID: 1198418
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fibrinogen Bern III: a further case of hereditary fibrinogen variants with substitution A alpha 16 Arg----Cys].
    Furlan M; Leupin L; Biasiutti FD; Lämmle B
    Schweiz Med Wochenschr; 1991 Jul; 121(29):1068-71. PubMed ID: 1891701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic and chemical cross-linking of fibrinogen.
    Furlan M; Beck EA
    Bibl Haematol; 1977; 44():123-8. PubMed ID: 104705
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrinogen New Orleans: hereditary dysfibrinogenemia with an A alpha chain abnormality.
    Andes WA; Chavin SI; Beltran G; Stuckey WJ
    Thromb Res; 1982 Jan 1-15; 25(1-2):41-50. PubMed ID: 6801812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen Kanazawa: a congenital dysfibrinogenaemia with delayed polymerization having a replacement of proline-18 by leucine in the A alpha-chain.
    Uotani C; Miyata T; Kumabashiri I; Asakura H; Saito M; Matsuda T; Kajiyama S; Iwanaga S
    Blood Coagul Fibrinolysis; 1991 Jun; 2(3):413-7. PubMed ID: 1932527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Criteria for the differentiation of dysfibrinogenemic states.
    Ratnoff OD; Forman WB
    Semin Hematol; 1976 Apr; 13(2):141-57. PubMed ID: 779032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen Bergamo III and fibrinogen Torino: two further variants with hereditary molecular defects in fibrinopeptide A.
    Reber P; Furlan M; Beck EA; Barbui T
    Thromb Res; 1987 Apr; 46(1):163-7. PubMed ID: 3590111
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinogen Barcelona II: a new case of A alpha 16 Arg----His substitution.
    Borrell M; Vila L; Solá J; Coll I; Fontcuberta J
    Haemostasis; 1990; 20(1):1-7. PubMed ID: 2323678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.